Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1952 Jul 1;96(1):55–58. doi: 10.1084/jem.96.1.55

HOMOTYPIC COMPLEMENT-FIXING ANTIBODY IN MONKEYS INFECTED WITH TYPE 2 POLIOMYELITIS VIRUS BY THE ORAL ROUTE

Jordi Casals 1, Peter K Olitsky 1, Albert B Sabin 1
PMCID: PMC2136125  PMID: 14946328

Abstract

CF tests with Type 2 poliomyelitis antigen (MEF1) were performed on the pre- and postinfection sera of 20 cynomolgus monkeys which developed paralytic, non-paralytic, or inapparent infection following oral administration of a Type 2 strain of virus (Y-SK). All the monkeys developed neutralizing antibody, and 17 developed CF antibody in an original serum dilution titer of 1:4 or greater. The 3 monkeys which did not develop this level of CF antibody were in a group of 7 which died within 8 days after onset of paralysis. The CF titers were as high at 2 to 6 days after onset of paralysis in the other 4 moribund or dead monkeys as in the surviving animals tested 4 weeks after the first dose of virus and the CF titers were of the same order of magnitude in the groups with paralytic, non-paralytic, or inapparent infection. The Type 2 poliomyelitis CF titers developed in monkeys as a result of infection with homotypic virus were not greater than those found in human beings infected with heterotypic Type 1 poliomyelitis strains.

Full Text

The Full Text of this article is available as a PDF (225.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CASALS J., OLITSKY P. K., ANSLOW R. O. A specific complement-fixation test for infection with poliomyelitis virus. J Exp Med. 1951 Aug;94(2):123–137. doi: 10.1084/jem.94.2.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. CASALS J., OLITSKY P. K., SABIN A. B. Development, persistence, and significance of type 2, poliomyelitis complement-fixing antibody in man. J Exp Med. 1952 Jul;96(1):35–53. doi: 10.1084/jem.96.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. HAMMON W. M., ROBERTS E. C. Serum neutralizing antibodies to the infecting strain of virus in poliomyelitis patients. Proc Soc Exp Biol Med. 1948 Nov;69(2):256–258. doi: 10.3181/00379727-69-16682. [DOI] [PubMed] [Google Scholar]
  4. STEIGMAN A. J., SABIN A. B. Antibody response of patients with poliomyelitis to virus recovered from their own alimentary tract. J Exp Med. 1949 Oct;90(4):349–372. doi: 10.1084/jem.90.4.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Sabin A. B., Ward R. NATURE OF NON-PARALYTIC AND TRANSITORY PARALYTIC POLIOMYELITIS IN RHESUS MONKEYS INOCULATED WITH HUMAN VIRUS. J Exp Med. 1941 May 31;73(6):757–770. doi: 10.1084/jem.73.6.757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. VON MAGNUS H., MELNICK J. L. Antibody response in monkeys following oral administration of poliomyelitis virus. J Immunol. 1948 Dec;60(4):583–596. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES